Notification for WTO member countries under Canada's Access to Medicines Regime
Countries that are members of the World Trade Organization (WTO), as listed on Schedule 3 to Canada's Patent Act, are required to notify the WTO of their plans to use Canada's Access to Medicines Regime (model notification letter). For instructions on how to provide notice, see Notifying the World Trade Organization.
Countries must disclose the following information to the WTO when planning to use the Regime:
For a graphic illustration of the notification process, see the process map for Schedule 3 countries.
Report a problem or mistake on this page
- Date modified: